Skip to content
healthcare.dev

Astringent

NDC 63561-0178, Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate, powder, for solution, from Granulation Technology, Inc..

Product NDC
63561-0178
Status
Listed
Labeler
Granulation Technology, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
part347
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0178 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM ACETATE MONOHYDRATE952 mg/2299mg
  • ALUMINUM SULFATE TETRADECAHYDRATE1347 mg/2299mg

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

Package NDCNDC-11Package
63561-0178-26356101780212 PACKET in 1 CARTON (63561-0178-2) / 2299 mg in 1 PACKET (63561-0178-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63561-0178 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0178 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63561-0178. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.